Stay Updated with the Latest Safe and Green Development Corporation SGD News in Real Time
Find SGD news now at Meyka AI. Stay informed with the latest Safe and Green Development Corporation stocks updates, including price news, market analysis, and expert insights.
Malaysia’s Ex-PM Ismail Sabri Charged With Concealing $40M in Assets on August 27
Ismail Sabri Yaakob, Malaysia’s shortest-serving PM, charged with concealing US$40M in undeclared assets including foreign currencies and gold bars. Faces up to 5 years prison if convicted.
EasyJet Strands 100+ Passengers in Tunisia After Belfast Flight Cancellation
Over 100 EasyJet passengers stranded in Tunisia after 22 August flight cancellation to Belfast. Airline blamed technical issues; passengers report poor communication and costs up to £4,000 for rebooking.
Nepal Floods Kill 359 as Glacier Collapse Triggers Himalayan Disaster; 34 Australians Missing
Glacier collapse in Nepal Himalayas triggers deadly flash floods killing 359 people. 34 Australians among nearly 1,500 missing as rescue efforts continue across Nepal-Tibet border.
Melbourne Man Charged After Stabbing Mother, Punching Boy With Brain Cancer on August 26
27-year-old Jerry Sowood charged with stabbing a mother and punching her 10-year-old son with brain cancer outside Melbourne police HQ. Both victims survived; he remains in custody.
Nvidia Guides 70% Growth for Fiscal 2028 After Q2 Revenue Doubles to $96.2B
Nvidia beats Q2 earnings with $96.2B revenue, up 106% YoY. CEO Jensen Huang forecasts 70% fiscal 2028 growth, far exceeding analyst consensus. Data center revenue surges 117% as AI demand accelerates.
US and China Race for Pacific Deep-Sea Mining as Australia Faces Pressure to Act
US and China compete for Pacific deep-sea mining of critical minerals worth USD 30 trillion. Australia faces pressure to shape international governance before operations start in 2027.
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…
Shein Sets Hong Kong IPO Price at HK$48.56, Valuing Fast-Fashion Giant at $26.5 Billion
Shein will price its Hong Kong IPO at HK$48.56 per share, people familiar with the matter said Thursday. The price sits near the midpoint of its HK$47.60 to HK$49.50 marketed range. The deal values Shein at roughly $26.5 billion, confirming weeks of investor pushback on valuation. Final Pricing Details Shein’s pricing will raise approximately HK$13.6…
Nvidia Beats Q2 Targets With $96.2B Revenue, Stock Falls 1.6% on August 27
Nvidia beat Q2 earnings with $96.2B revenue and $2.22 adjusted EPS, but stock fell 1.6%. Q3 guidance of $108B signals strong AI chip demand ahead.